About Avadel Pharmaceuticals plc

Who We Are: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, currently approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. Our current lead drug candidate, LumryzTM (sodium oxybate) extended release for oral suspension (formerly known as FT218), applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night’s sleep. An extended-release medication sounds like a simple innovation, but it is what has been lacking for 20 years and we believe this will be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.

What We Do: LumryzTM has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy. The designation was granted on the plausible hypothesis that LumryzTM may be clinically superior to a formulation of sodium oxybate already approved by the FDA for the same indication.

The FDA granted a tentative approval to LumryzTM on July 18, 2022. Tentative approval indicates that LumryzTM has met all required quality, safety, and efficacy standards necessary for approval in the U.S. FDA’s final approval decision for LumryzTM is pending expiration or other disposition of a patent listed in FDA’s Orange Book that expires on June 17, 2023. Avadel’s market research suggests that LumryzTM has the potential to command a meaningful share of the multi-billion-dollar narcolepsy treatment market.

We are currently taking steps to accelerate the final approval of LumryzTM earlier than the expiry of the patent in June 2023, however, in either case, we are gearing up for our full launch now. We can’t wait to bring an innovative new treatment option to the narcolepsy community.

How We Work: At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage – our “secret sauce”. The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility, being courageous, taking insights to impact, and togetherness. In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.

We are seeking team members who have a passion for making a meaningful impact in the lives of patients. We need individuals who will dive in, roll up their sleeves, and join us in our mission to launch LumryzTM for the narcolepsy community and be part of building and shaping an exciting future together.

Position Summary:
This is a unique opportunity to build and manage a world-class data and analytics environment. If you get charged up by all things related to data science and are looking for a hands-on role in shaping the future of data and analytics in a small, fast-paced, fun, high growth, pre-launch pharma company, then let’s talk. This is a highly visible role for someone who wants to roll up their sleeves and bring our vision of world class data management, analytics, and data science to life. This work will be focused on our first-launch brand and will be an instrumental part of a high performing Strategic Market Insight & Commercial Analytics (SMICA) team.

The Associate Director of & Commercial Analytics and Data Science will be responsible for the development and implementation of Avadel’s Commercial Analytics environment and all functional, field and headquarter reporting. This role will be responsible for all secondary data management, forecasting, business analytics, patient services support and integrating data together to have a holistic view on how to best understand the narcolepsy market to ultimately turn insights into action. S/He will be instrumental in shaping the insights supporting launch performance and brand health tracking. S/He will be accountable for identifying new and emerging business issues and identifying data science approaches to addressing these issues and solving problems across the entire Commercial Organization.

Essential Functions:

• Commercial Analytics:
  • Lead all aspects of commercial data management, key performance indicators, and field, functional, and headquarter reporting. Manage external partners to maintain smooth and efficient data management and operations.
  • Translate data research and numbers into actionable insights that are focused on generating superior patient outcomes.
  • Connect multiple data sources to create a more holistic view of the U.S. market; continually identify new data sources that will enable a more complete, holistic views
  • Construct and update Key Performance Indicator (KPI) dashboards.
  • Manage and lead Advanced Analytical projects (segmentation, targeting, journey analytics, promotional response, predictive triggers to name a few)
  • Develop and track performance for short- and long-range forecasts.
• Brand Performance: Monitor regular brand performance and prepare monthly insights deliverable, performance updates, and ad hoc analyses based on synthesis / analysis of a variety of primary / secondary data sources (e.g., market research, prescribing data, competitive intelligence, field team feedback, customer feedback). Must have excellent knowledge of major US data sources, and ability to drive deep analytics on performance and market dynamics.
• Market Research: Collaborate with other SMICA team members to understand and synthesize primary market research. This individual will be an expert in Insight Generation supporting US Brand and broader Commercial team.
• Collaborate with all key stakeholders which includes sales, market access, medical, the R&D organization, finance, legal, HR and so many other key partners.
• Drive the spirit of ONE Team across all functions to support a full team approach to focus on our patients and customers as our top priorities.

Experience and Qualifications:

• BA or BS degree required. Master's degree in Computer Sciences, Business, or related areas would be preferred.
• 5-7 years in commercial analytics, 3 years in advanced data analytics, or related field with responsibilities in data strategy and governance, or digital analytics
• Must have experience with life sciences data sources
• Strong knowledge of Pharma and Life Sciences industry, with preference for individuals with Life Sciences consulting background.

• For the health and safety of our employees, customers, and community, vaccination against COVID-19 is required as a condition of employment for this position and you must provide valid proof of vaccination.

Competencies and Behaviors:

• High Analytical Horsepower / Skillset – high comfort sourcing, manipulating, analyzing using basic tools (Excel) and visualizing data via standard tools/charting methods; ability to effectively present and defend analyses. Expert knowledge of data science / advanced analytics methods and techniques with the ability to drive select projects internally and leveraging the expertise of external experts as appropriate.
• Strong Project / Deliverable Management – ability to deliver complex analytical investigations and cross-functional projects with limited guidance; ability to scope, enhance the output/hypotheses and deliver analytical investigations and projects with limited oversight; seeks to understand the problem/issue, conducts cross-functional interviews and drives towards a well-structured deliverable
• High Customer-Orientation – internal customers as a service partner to marketing + other functions
• Strong Communications – both efficient and succinct in verbal and written communications/deliverables; able to distill complex analyses into meaningful insights and conclusions for executive audiences
• Cross-Functional Collaboration and Project Management – able to collaborate effectively with various functional partners to probe/ask questions, gather required information for analysis and participate as a value-added cross-functional partner
• Dealing Well with Ambiguity / Intensity – operates well in a fast-paced environment driven by senior leadership requests and evolving needs
• Independence – able to manage workload with limited guidance and support in prioritization; effective managing to expectations and ability to scope/prioritize work with relatively high independence

Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.